Who
Edward W. Holmes
Director
Company insider
Files Form 4 as: Director, Arcturus Therapeutics Holdings.
In numbers
- Trades disclosed
- 13
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 25 Oct 2019
- Last trade
- 5 Jun 2026
- Last filed
- 15 Jun 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jun 2026filed 15 Jun 2026 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 5 Jun 2026filed 15 Jun 2026 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 9 Jun 2025filed 11 Jun 2025 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code M | —3,131 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 14 Jun 2024filed 18 Jun 2024 | ARCT Arcturus Therapeutics HoldingsBiotechnology | SEC FORM 4 Code M | —3,131 at $0.00 | filing |
| 1 Aug 2023filed 3 Aug 2023 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —11,869 at $0.00 | filing |
| 1 Aug 2023filed 3 Aug 2023 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —3,131 at $0.00 | filing |
| 23 Jun 2022filed 27 Jun 2022 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 18 Jun 2021filed 22 Jun 2021 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 22 Jun 2020filed 24 Jun 2020 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 25 Oct 2019filed 29 Oct 2019 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 25 Oct 2019filed 29 Oct 2019 | ARCT Arcturus Therapeutics Holdingsoption or derivative · Biotechnology | SEC FORM 4 Code A | —20,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.